(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...
Explore Eli Lilly and Company stock: obesity drug tirzepatide sales +115%, new retatrutide diabetes data, and Kisunla ...
HealthDay on MSN
Heart benefits from GLP-1 drugs fade after stopping, study finds
Key Takeaways GLP-1 drugs can lower heart risk while you take themHeart risks start to rise within six months of stopping, ...
A recent study outlines the cardiovascular benefits of staying on GLP-1 diabetes drugs, highlighting the risks of discontinuation. Furthermore, research on physical activity suggests early morning ...
All sleek, no sizzle ...
Inside the supplement industry’s “pixie dusting” problem and why vitamin traceability is becoming the new standard for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results